Navigation Links
EZ Breathe(R) Home Ventilation System Expels Allergens, Moisture and Smells
Date:5/28/2009

MACEDONIA, Ohio, May 28 /PRNewswire/ -- Annoying seasonal allergies is now a year round threat. Today's more tightly sealed, energy efficient homes encourage allergens to nest in the home. Indoor air pollution is a newly identified phenomenon caused by the myriad of chemicals, synthetic materials and impurities. To expel these year round risks, EZ Breathe offers a truly revolutionary approach to home ventilation and eliminates allergens.

The EZ Breathe system improves indoor air quality and eliminates conditions for mold to grow. Filter-free and cartridge-free, EZ Breathe does not require additional cost to maintain. Soundless and virtually maintenance-free, EZ Breathe ventilates by drawing moist, stale, contaminated air out of the home, replenishes by replacing moist air with fresh dry air and regulates airflow to reach and maintain a desired level of humidity. A complete home air exchange occurs about 6 to 10 times each day and EZ Breathe covers up to 7000 square feet, operating at a mere $2-$4 per month!

EZ Breathe Offers Complete, Balanced Home Ventilation:

Proven: This patented, third-generation system is the result of a continuous R&D effort that builds on the success of the original EZ Breathe system

Versatile: Ideal solution for slabs, basements and crawlspaces

Energy-Efficient: Operating at 40 watts, the EZ Breathe system only costs $2-$4 per month to operate

Balanced: Unlike other systems, EZ Breathe expels stale air and replaces it with clean, conditioned air - and then circulates that fresh air throughout the home

Cost effective: At a mere third of the cost of ERV and HRV systems, EZ Breathe is the economical choice

Maintenance-Free: Easy-to-use and Easy-to-clean, EZ Breathe requires only a quick vacuum

About EZ Br
'/>"/>

SOURCE EZ Breathe
Copyright©2009 PR Newswire.
All rights reserved

3

GOOD

Page: 1 2

Related medicine news :

1. Measures to assess potential lung injury during ventilation inadequate
2. Educating physicians about ventilation-perfusion scanning leads to reduced radiation exposure
3. Aviation Ventilation Expert Available to Speak About Swine Flu Spread on Airplanes
4. Different method of evaluating the urinary tract system reduces radiation dose
5. Lutheran Senior Services Partners with Silverchair Learning Systems to Enhance Employee Training and Education
6. Exempla Healthcare Contracts For Talismans Quality Donor System
7. Heartline(R) Fitness Systems Named to Inc. Magazines Inaugural List of the 5000 Fastest Growing Private Companies in U.S....
8. University of Wisconsin Hospitals and Clinics Complete System-Wide Conversion to Masimo SET Pulse Oximetry Technology
9. Plexus Systems Ranks in Top Third of the 2007 Inc. 5,000 with Three-Year Sales Growth of 226%
10. Document Security Systems (Amex: DMC) Invites You to a Landmark Event
11. Flu Vaccinations Begin on September 29 Maxim Health Systems to Provide 24,000 Flu Shot Clinics Nationwide
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Maxygen, Inc. Announces Extension of Dutch Auction Tender Offer 2Boston Scientific Announces Pricing of $2 Billion of Senior Notes 2Boston Scientific Announces Pricing of $2 Billion of Senior Notes 3Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 2Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 3Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 4Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 5Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 6JumpStart Invests in Checkpoint Surgical 6118 1JumpStart Invests in Checkpoint Surgical 6118 2JumpStart Invests in Checkpoint Surgical 6118 3Some chest pain patients wait longer than 10 minutes to see ER physician 61033 1Some chest pain patients wait longer than 10 minutes to see ER physician 61033 2Volcano Corporation Presentation at Canaccord Adams Conference to Be Webcast 6115 1Volcano Corporation Presentation at Canaccord Adams Conference to Be Webcast 6115 2
Other Medicine Technology:Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV 2Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV 3Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV 4Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV 5Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV 6Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV 7Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV 8Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV 9Video: Actress and New Mom Keri Russell Joins PKIDs to Launch 'Silence the Sounds of Pertussis' Campaign 2Video: Actress and New Mom Keri Russell Joins PKIDs to Launch 'Silence the Sounds of Pertussis' Campaign 3